Nijdam Anna reported option exercise involving 5,501 derivative units of Pharvaris N.V. at $0.00 for $0 on May 22, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Principal Accounting Officer
Principal Accounting Officer
Filed May 26, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
5,501Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
22,670Direct
Trade date
May 22, 2026Option exercise
Filed
May 26, 2026, 5:45 PM ET4-day reporting delay
Accession
0001193125-26-239733Code M · Transaction 385115
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 21, 2026Option exercise1,829$20.00$36,580Trade 385110
May 22, 2026Option exercise5,501$20.00$110,020Trade 385112
May 21, 2026Option exercise1,829$0.00$0Trade 385114
May 21, 2026Sell1,829$30.60−$55,971.24Trade 385111
May 22, 2026Sell5,501$30.74−$169,084.24Trade 385113
6 transaction rows in this filing. Joint filers share the same rows.

PHVS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PHVS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +0.5%1w ago +1.7%1d ago +2.2%
Returns since7d −3%30d +11%90d +25%180d1y

Footnotes in full

F1: On April 14, 2026, the reporting person reported an RSU vesting transaction in which 5 additional shares were inadvertently reported as withheld for tax obligations, resulting in an understatement of total beneficial ownership. Following correction of the tax withholding share amount, total beneficial ownership as of April 11, 2026 should have been 48,945 shares rather than 48,940 shares reported previously. F2: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $30.60 to $30.61. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $30.60 to $31.00. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F4: 25% of the option vested on February 5, 2022 with the remaining shares vesting in 1/48 monthly installments thereafter.